Conestoga Capital Advisors LLC Grows Stock Holdings in Stevanato Group S.p.A. (NYSE:STVN)

Conestoga Capital Advisors LLC lifted its stake in Stevanato Group S.p.A. (NYSE:STVN) by 1.3% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 8,189,926 shares of the company’s stock after purchasing an additional 106,930 shares during the quarter. Stevanato Group comprises approximately 2.5% of Conestoga Capital Advisors LLC’s holdings, making the stock its 14th largest position. Conestoga Capital Advisors LLC’s holdings in Stevanato Group were worth $167,238,000 as of its most recent SEC filing.

A number of other large investors have also added to or reduced their stakes in STVN. Truist Financial Corp grew its stake in shares of Stevanato Group by 4.2% in the fourth quarter. Truist Financial Corp now owns 26,900 shares of the company’s stock worth $586,000 after acquiring an additional 1,073 shares during the last quarter. Peregrine Capital Management LLC boosted its stake in Stevanato Group by 1.9% in the 4th quarter. Peregrine Capital Management LLC now owns 366,078 shares of the company’s stock worth $7,977,000 after purchasing an additional 6,661 shares in the last quarter. New York State Common Retirement Fund purchased a new stake in Stevanato Group during the 4th quarter valued at about $8,879,000. TimesSquare Capital Management LLC increased its stake in Stevanato Group by 114.6% during the 4th quarter. TimesSquare Capital Management LLC now owns 3,288,529 shares of the company’s stock valued at $71,657,000 after purchasing an additional 1,756,100 shares in the last quarter. Finally, First Bank & Trust increased its stake in Stevanato Group by 7.3% during the 4th quarter. First Bank & Trust now owns 15,145 shares of the company’s stock valued at $330,000 after purchasing an additional 1,036 shares in the last quarter.

Analyst Ratings Changes

STVN has been the topic of several analyst reports. Stephens upgraded shares of Stevanato Group to a “strong-buy” rating in a research note on Monday, April 21st. UBS Group lowered their price objective on Stevanato Group from $24.00 to $23.50 and set a “neutral” rating on the stock in a research report on Friday, March 7th. Finally, William Blair reiterated an “outperform” rating on shares of Stevanato Group in a research note on Friday, March 7th. Two research analysts have rated the stock with a hold rating, four have given a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, Stevanato Group has a consensus rating of “Moderate Buy” and an average target price of €25.70 ($29.88).

Stevanato Group Stock Up 2.5%

STVN opened at €24.07 ($27.99) on Tuesday. The stock has a market capitalization of $7.29 billion, a price-to-earnings ratio of 51.21, a PEG ratio of 7.18 and a beta of 0.53. The firm has a 50 day moving average price of €22.55 and a 200-day moving average price of €21.65. Stevanato Group S.p.A. has a twelve month low of €16.56 ($19.26) and a twelve month high of €25.75 ($29.94). The company has a quick ratio of 1.21, a current ratio of 1.81 and a debt-to-equity ratio of 0.22.

Stevanato Group Increases Dividend

The business also recently announced an annual dividend, which will be paid on Thursday, July 17th. Shareholders of record on Thursday, June 5th will be paid a dividend of $0.0613 per share. The ex-dividend date is Thursday, June 5th. This is a positive change from Stevanato Group’s previous annual dividend of $0.05. This represents a yield of 0.3%. Stevanato Group’s payout ratio is currently 11.76%.

Stevanato Group Company Profile

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.